Optimization of the peritoneal lavage

Diagnostic Cytopathology

Volumn 18, Issue 4, 1998, Pages 265-269

  Walts, Ann E ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cytology; Peritoneal lavage; Peritoneal washing

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERITONEUM LAVAGE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; PERITONEAL LAVAGE; SENSITIVITY AND SPECIFICITY;

EID: 0031897449     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199804)18:4<265::AID-DC3>3.0.CO;2-B     Document Type: Article

References (18)

1. Keettel WC, Elkins HB. Experience with radioactive colloidal gold in the treatment of ovarian carcinoma, Am J Obstet Gynecol 1956;71:553-565.
2. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: Lippincott, 1993:155-180.
3. Spriggs AI. Cytology of peritoneal aspirates and washings (commentary). Br J Obstet Gynaecol 1987;94:1-3.
4. Cain JM, Saigo PE, Pierce VK, et al. A review of second-look laparotomy for ovarian cancer. Gynecol Oncol 1986;23:14-25.
5. Keetel WC, Pixley EE, Buchsbaum HJ. Experience with peritoneal cytology in the management of gynecologic malignancies. Am J Obstet Gynecol 1974;120:174-182.
6. Makar APH, Trope CG, Endometrial and ovarian malignancies: epidemiology, etiology, and prognostic factors. Acta Obstet Gynecol Scand 1992;71:331-336.
7. Geszler G, Szpak CA, Harris RE, Creasman WT, Barter JF, Johnston WW. Prognostic value of peritoneal washings in patients with malignant mixed Mullerian tumors of the uterus. Am J Obstet Gynecol 1986;155:83-89.
8. Kanbour AI, Buchsbaum HB, Hall A, Kanbour A. Peritoneal cytology in malignant mixed Mullerian tumors of the uterus. Gynecol Oncol 1989;33:91-95.
9. Shin HJ, Sneige N. The role of peritoneal washing cytology in patients with serous borderline tumor (SBT) of ovary. Acta Cytol 1996;40:1057.
10. Abu-Ghazeleh S, Johnston W, Creasman WT. The significance of peritoneal cytology in patients with carcinoma of the cervix. Gynecol Oncol 1984;17:139-148.
11. Mulvany N, Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids. Acta Cytol 1996;40:1231-1239.
12. Rubin SC, Dulaney ED, Markman M, Hoskins WJ, Saigo PE, Lewis JL. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Obstet Gynecol 1988;71:851-853.
13. Pretorius RG, Lee KR, Papillo J, Baker S, Belinson J. False-negative peritoneal cytology in metastatic ovarian carcinoma. Obstet Gynecol 1986;68:619-623.
14. Creasman WT, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1971;110:773-781.
15. Yoshimura S, Scully RE, Taft PD, Herrington JB. Peritoneal fluid cytology in patients with ovarian cancer. Gynecol Oncol 1984;17:161-167.
16. Ziselman EM, Harkavy SE, Hogan M, West W, Atkinson B. Peritoneal washing cytology. Uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol 1984;28:105-110.
17. Crosby JH, Allsbrook WC Jr, Pantazis CG, Otken LB Jr, Gallup DG, Talledo OE. Cytology and DNA flow cytometry of peritoneal washings in gynecologic patients. Mod Pathol 1992;5:153-157.
18. Copeland LJ, Gershenson DM, Wharton JT, et al. Microscopic disease at second-look laparotomy in advanced ovarian cancer. Cancer 1985;55:472-478.